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A Kunitz-type trypsin inhibitor was purified from Leaf-nosed viper venom and the primary structure determined by peptide analysis. In relation 
to other trypsin inhibitors, the protein has an extended C-terminal segment and a distinct pattern of residue alterations at the functionally important 
contact sites with proteases. 
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1. INTRODUCTION 
Snake venom contains serine protease inhibitors in 
addition to enzymes and toxins. Several of these inhibi- 
tors have been characterized from venoms of viperid 
and elapid snakes [l&4]. These inhibitors belong to the 
Kunitz-type trypsin inhibitor family present also in pan- 
creas [5]. Knowledge of primary structures of several 
members of the family is important for further under- 
standing of the interactions with serine proteases, since 
a number of variations within the contact areas with 
trypsin and related enzymes has been found [6]. 
The present report describes the purification and cha- 
racterization of Kunitz-type trypsin inhibitor from 
Leaf-nosed viper venom and demonstrates structural 
variations in the protease contact sites. 
2. MATERIALS AND METHODS 
Crude venom of Leaf-nosed viper was fractionated by Sephadex 
G-50 chromatography [7]. Fraction 2 (cf. Fig. 1 in [7]) containing 
inhibitor was further purified by reverse-phase HPLC on Vydac C,, 
(Phenomenex, New York) with a linear gradient of acetonitrile in 0.1% 
aqueous trifluoroacetic acid. The material corresponding to peak 2 
from this step was separated on Mono-S FPLC (Pharmacia) in 50 mM 
ammonium acetate, pH 4.8, with a linear gradient of 0- 0.5 M NaCl. 
The Pharmacia Phast system was used for SDS-polyacrylamide gel 
electrophoresis and Coomassie Phast blue R staining. 
The protein was reduced with dithiothreitol, carboxymethylated 
with “C-labelied iodoacetate [7] and cleaved in separate batches with 
Lys-C protease, and chymotrypsin, both in 0. I M ammonium bicarbo- 
nate (pH 8.1) at 37°C for 4 h with protcase/substrate ratios of 1:50. 
Total compositions were determined with an LKB 4151 Alpha plus 
amino acid analyzer after acid hydrolysis for 24 h in evacuated tubes 
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at 110°C with 6 M HCI containing 0.5% phenol. Amino acid sequen- 
ces were determined with an ABI 470A gas phase sequencer. 
3. RESULTS 
The separation of Leaf-nosed viper crude venom into 
5 fractions by Sephadex G-50 chromatography has been 
described [7]. The second fraction was now separated by 
reverse-phase HPLC (Fig. IA) and material corre- 
sponding to peak 2 was purified further by FPLC on 
Mono-S (Fig. 1B). Peak 5 of the Mono-S chroma- 
togram corresponded to a homogeneous band on SDS- 
polyacrylamide gel electrophoresis at an apparent mo- 
lecular mass of about 6.5 kDa. The primary structure 
of this material was established by sequence analysis of 
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Fig. 1. Purification of Leaf-nosed viper trypsin inhibitor. (A) HPLC 
on Vydac C,, in 0.1% trifluoroacctic acid with a linear gradient of 
acetonitrile; starting material: Sephadex G-50 fractionated venom, 
fraction 2 [7]. (B) FPLC on Mono-S in 50 mM ammonium acetate with 
a linear gradient of NaC1; starting material corresponding to peak as 
indicated in (A). 
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FCYLPDDPGVCKAHIPRFYYNPASNKCKNFIYGGCGGNANNFETRAECRHTCVASGKGGPRP 
~K1-----i -K2------1 t------------_K3P I-K4---I 
-cl- -21 t---c4--l ~C5------+ 
Fig. 2. Primary structure of Leaf-nosed viper trypsin inhibitor and the positions of peptides analyzed. K (K I K4) indicates peptides from Lys-C 
cleavage and C (Cl CS) represents those from chymotrypsin clcavagc. 
peptides from separate digests with Lys-C protease and 
chymotrypsin. The amino acid compositions of the in- 
tact protein (Table I) and peptides are in agreement with 
the compositions from sequence analysis (Fig. 2). 
The structure determined is homologous, with respect 
to both amino acid sequence and positions of Cys resi- 
dues, to Kunitz-type protease inhibitors characterized 
from venom and other sources. 
4. DISCUSSION 
The Kunitz inhibitor was isolated from Leaf-nosed 
viper venom by a combination of gel filtration, reverse- 
phase HPLC and cation exchange FPLC. The 62 pri- 
mary structure has six Cys residues. The Cys pattern 
and the entire-chain homology identify the venom com- 
ponent as a Kunitz-type inhibitor. A feature unlike that 
for most of the other many characterized trypsin inhibi- 
tors is a 6 residue extended C-terminal segment (Fig. 3). 
Interestingly, however, a similar pattern of C-terminal 
extension has been observed also for the chymotrypsin 
inhibitor of the venom of the closely related species 
Long-nosed viper [3]. Other molecules with extended 
C-termini from non-venom sources are represented by 
protease inhibitors from bovine colostrum [S] and turtle 
egg white [9]. The structural or functional role of the 
extended C-terminal segment is not known. 
X-Ray crystallographic studies of Kunitz-type pro- 
tease inhibitors have resulted in the characterization of 
two contact sites with proteases, a main one and a weak 
one [lo]. The specificity of the inhibitor towards pro- 
teases has been found to be associated with the main 
contact site. Thus, a basic residue, Lys/Arg, at position 
15 (homology number in Fig. 3) within the main contact 
site is considered to be essential for trypsin inhibitor 
activity [4]. 1n contrast, residues like Phe, Leu and Tyr 
at this position are typical for chymotrypsin inhibitors 
[l I]. The presence of Lys at this position, thus identifies 
the polypeptide chain as a Kunitz-type trypsin inhibitor. 
Known relationship for the basic pancreatic trypsin in- 
hibitor and other inhibitors within this family now 
allow further functional conclusions on protease inter- 
acting residues at critical positions [l2]. 
The residues involved in the main contact site and at 
the region of the weak contact site with serine proteases 
142 
are well conserved (Fig. 3). The only exchange, at the 
main contact site, is a hydrophobic residue Val-13, in- 
stead of a basic rcsiduc, Arg in closely related viper 
venom inhibitors (Fig. 3). Notably, a similar exchange 
was also observed in the trypsin inhibitor characterized 
from the elapid snake Nc!jll nqju ncrjcr [4], where Arg is 
exchanged for Leu as shown in Fig. 3. 
The residue identity between this polypcptidc chain 
and those of the group of other venom inhibitors is 
considerably higher than that between the present in- 
hibitor and the phylogenetically distant bovine inhibitor 
(Fig. 3). The most extensive similarity was found with 
the trypsin inhibitor of a closely related species, Long- 
nosed viper (72% residue identity) [2]. The main and 
weak contact sites of this inhibitor are identical to those 
of the Long-nosed viper except for one exchange at both 
sites, i.e. Arg-13 at the main contact site and Pro-39 at 
the weak contact site. The residue identity with trypsin 
inhibitor of bovine pancreas, N+ naju nuju, and Rus- 
sel’s viper is fairly distant (43-60%). 
Table I 
Total composition of the trypsin inhibitor 
__ 
Residue 
CYS 
Asp 
> Asn 
Thr 
Ser 
GIU 
Gln ) 
Pro 
GlY 
Ala 
Val 
Ile 
Leu 
Tyr 
Phe 
Lys 
His 
Arg 
Acid hydrolysis Sum of sequence 
5.1 6 
8.1 
{ 
2 
6 
1.5 2 
1.7 2 
2 
2.3 
{ 0 
6.2 6 
8.4 8 
4.8 5 
1.6 2 
I.8 2 
I.1 I 
4.2 4 
3.9 4 
4.3 5 
I.5 2 
4.1 4 
Sum 62 
Values represent molar ratios after acid hydrolysis and sequence anal_ 
ysis. Cys analyzed as Cys(Cm). 
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1. FCyLpDDpGVCKAHIPRFYYNPASNKCKNFIYGGCGGNANNFETRAECRHTCVASGKGGPRP 
2. DHPKFCYLPADPGRCKAHIPRFYYDSASNKCNKFIYGGCPGNANNFKTWDECRQTCGASA 
3. HDRPTFCNLAPESGRCRGHLRRIYYNLESNKCEVFFYGGCGGNANNFETRDECRETCGGK 
4. RPGFCELPAAKGLCKAHKPAFYYNKDSHRCQKFIYGGCGGNANRFRTIDECNRTCVG 
5. RPDFCLEPPYTGPCKARIIRYFYNAKAGLCQTFVYGGCRAKRNNFKSAEDCMRTCGGA 
Fig. 3. Comparison of amino acid sequence of the trypsin inhibitor from Leaf-nosed viper. Trypsin inhibitor now characterized (top line) is aligned 
with trypsin inhibitors from I,ong-nosed viper [2], Russel’s viper [I]. NC+/ nuju ntrjtr [4] and bovine pancreas, 1131 as listed 2-5. Residues at the main 
and the weak contact sites of the inhibitor with proteases arc indicated by @, and asteriks, respectively. Sequence homology numbers are given 
according to the sequence of bovine pancreatic trypsin inhibitor [13]. 
nc,kr~o~~lec/jier,r~/~/,~~ We arc grateful to the Swedish Institute for a 
fellowship grant and to Carina Palmbcrg for drawings. Grants from 
Karolinska lnstitutet and the Pakistan Science Foundation (Project 
SKU-163) arc also gratefully acknowledged. 
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